Michael Nall

Michael Nall has a diverse work experience in the biotechnology and healthcare industries. Michael is currently serving as the Chief Commercial Officer (CCO) at Biological Dynamics, starting in November 2022. In addition, they are a Board Member at NONIGENEX since April 2022 and at Clearity since June 2019.

Prior to their current roles, Nall held the position of President and CEO at Biocept from September 2013 to February 2022. During their tenure, they led the company through multiple financing rounds, resulting in rapid growth and profitability. The team size grew from 20 employees in 2013 to nearly 200 in 2022.

Before Biocept, Nall worked at General Electric - Clarient, GE Healthcare, and Clarient in various sales and managerial positions. Michael'sresponsibilities included overseeing North American sales and marketing as the General Manager at General Electric - Clarient from March 2002 to August 2013, and serving as VP of Sales and Managed Care at GE Healthcare from March 2002 to July 2012.

Nall also worked as a Vice President and Director of Sales at Clarient, where they played a key role in team expansion and revenue growth.

Michael'searlier experience includes roles as an Account Executive at ChromaVision Medical Systems, Inc. from March 2002 to March 2004, and at Impath from November 1999 to March 2002.

Overall, Michael Nall has a strong background in leadership, sales, and management within the biotechnology and healthcare sectors.

Michael Nall has a Bachelor of Science (BS) degree in Business Administration and Management, with a field of study in General Business Administration. Michael obtained this degree from the University of Central Missouri.